J.P. Morgan Exchange-Traded Fund Trust - JPMorgan International Research Enhanced Equity ETF EBIT

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan International Research Enhanced Equity ETF posts a EBIT of $-75M as of June 2026. That compares with $-31M in the prior-year period — down 144.8% year over year. That is below the sector sector average of $-6.4M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, J.P. Morgan Exchange-Traded Fund Trust - JPMorgan International Research Enhanced Equity ETF's EBIT was $-31M. The latest reading is $-75M — a 144.8% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a EBIT near $-6.4M is typical. J.P. Morgan Exchange-Traded Fund Trust - JPMorgan International Research Enhanced Equity ETF's $-75M is lower that level. That is roughly 1066.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of J.P. Morgan Exchange-Traded Fund Trust - JPMorgan International Research Enhanced Equity ETF's financial statement story. At $-75M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for JIRE's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $-6.4M), and (3) consistency with growth and profitability. This page covers the first two; J.P. Morgan Exchange-Traded Fund Trust - JPMorgan International Research Enhanced Equity ETF's other metric pages and overview cover the third.